Bristol Myers Squibb Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Bristol Myers Squibb stocks.

Bristol Myers Squibb Stocks Recent News

Date Stock Title
May 15 SNY Novavax Stock Just Tripled. Is It Too Late to Buy?
May 14 RAPT Wolfe downgrades RAPT, but still sees "immense" upside potential
May 14 SNY Sanofi to make €1bn biomanufacturing investment in France
May 14 SNY Does Soaring Novavax Stock Have Enough Fuel to Climb Higher?
May 14 SNY Trending tickers: Anglo American, GameStop, Vodafone, Greggs and Novavax
May 14 SNY Fulcrum Therapeutics Inc (FULC) Q1 2024 Earnings Call Transcript Highlights: Strategic ...
May 14 SNY Exploring Three Dividend Stocks On Euronext Paris
May 13 BMY Bristol-Myers Squibb Company (BMY) Presents at Guggenheim Securities Radiopharmaceuticals Day (Transcript)
May 13 SNY Barrow, Hanley, Mewhinney & Strauss Bolsters Portfolio with Strategic Additions in Q1 2024
May 13 SNY Novavax (NVAX) Q1 Earnings Miss, Stock Soars on Sanofi Deal
May 13 BMY One stock is dragging down the S&P 500's earnings growth
May 13 SNY Meme Mania is Back: Buy these 3 Stocks
May 13 BMY BMS and Zai Lab’s Augtyro gains NMPA approval to treat NSCLC
May 13 SNY Healthcare Giants Pfizer, AstraZeneca, Sanofi Inject Over $2B To Boost France's Healthcare Sector
May 13 BMY Bristol Myers (BMY) Fails to Meet Goal in Opdivo NSCLC Study
May 13 BMY These Stocks Are Moving the Most Today: GameStop, AMC, Arm, Squarespace, Tesla, Intel, Apple, Incyte, and More
May 13 SNY Sanofi strikes $1bn deal with Fulcrum for muscular dystrophy drug
May 13 SNY Sanofi (SNY), Regeneron's Dupixent sBLA Gets FDA Priority Tag
May 13 SNY Sanofi gains license for ex-U.S. rights to Fulcrum muscular dystrophy candidate
May 13 SNY Biggest stock movers today: ARM, ZK, TME, GME, and more
Bristol Myers Squibb

Bristol-Myers Squibb Company (BMS) is an American pharmaceutical company, headquartered in New York City.
Bristol-Myers Squibb manufactures prescription pharmaceuticals and biologics in several therapeutic areas, including cancer, HIV/AIDS, cardiovascular disease, diabetes, hepatitis, rheumatoid arthritis and psychiatric disorders.
BMS' primary R&D sites are located in Lawrence, New Jersey (formerly Squibb, near Princeton) and Wallingford, Connecticut (formerly Bristol-Myers); with other sites in East Syracuse, New York; Princeton Pike, Hopewell Township and New Brunswick, New Jersey; and in Swords, Ireland; Braine-l'Alleud, Belgium; Tokyo, Japan; and Bangalore, India.

Browse All Tags